: Biogen and Eisai release new Alzheimer’s drug data that may support wider uptake 0 26.10.2023 00:28 MarketWatch.com Eisai plans to apply for FDA approval of subcutaneous Leqembi by early next year. Партнёры Smi24.net Все новости за 24 часа Музыкальные новости Агрегатор новостей 24СМИ
